Yes, Multiple System Atrophy (MSA) significantly affects body temperature regulation by impairing the autonomic nervous system, leading to reduced sweating (anhidrosis), heat intolerance, and often cold hands and feet, making individuals prone to overheating in hot conditions or feeling cold. This inability to sweat properly disrupts the body's natural cooling mechanism, requiring careful management of environmental temperatures.
Multiple system atrophy (MSA), formerly called Shy-Drager syndrome, is a rare condition of the brain and nervous system. MSA affects the body's ability to control automatic processes (body functions that you don't have to think about) such as breathing, digestion, heart rate, movement, and blood pressure.
Decreased ability to sweat
People with Multiple System Atrophy (MSA) may have trouble regulating their body temperature due to a reduced ability to sweat. This condition is known as anhidrosis.
People living with MSA may experience periods of low mood, depression and/or anxiety, yet mental health is often overlooked at routine appointments with health and care professionals. Being able to recognise how MSA is affecting your mental health can help you to seek professional support when needed.
Those people with MSA-C present with balance, co-ordination and speech problems. Both men and women often experience problems with their bladders including urgency, frequency, nocturia, incomplete bladder emptying, or retention. Erectile dysfunction is an early symptom in male patients and is almost always present.
About 60% of people with MSA need to use a wheelchair about five years after the onset of MSA. Within six to eight years, at least half of those with this condition are bedridden.
The Red Flag indicators of serious pathology include:
Most commonly people with MSA experience increasing sluggishness of the bowel and risk a build-up of chronic constipation. You should aim to keep your bowel movements at least as regular as they were before you had MSA.
Medicines that treat Parkinson's disease, such as combined levodopa and carbidopa (Sinemet, Duopa, others), can help some people with MSA. The medicine can treat stiffness, trouble with balance and slow movements.
The first symptoms of MSA are frequently autonomic and may predate recognition of motor manifestations. Orthostatic hypotension and, in men, erectile failure are among the first symptoms that, when evaluated in the context of associated clinical findings, may facilitate accurate and earlier diagnosis.
This instability can affect the legs, leading to difficulties with walking and increasing the risk of falls. Gait abnormalities: Changes in gait, including a shuffling or hesitant walk, reduced stride length and difficulty initiating movement are common with multiple system atrophy.
Patients with MSA may present with cerebellar or parkinsonism predominant phenotypes. Ocular symptoms include dry eye, saccadic abnormalities, and cerebellar nystagmus. There is no proven effective treatment for MSA and the prognosis is poor.
MSA is degenerative, which means that unfortunately symptoms are likely to worsen over a period of time.
Fatigue was prevalent in patients with early-stage MSA, MSA-P, and MSA-C, and the severity and frequency of fatigue increased with disease progression.
Impairment of the nerve co-ordination of the bladder, preventing proper emptying of the bladder, is common in MSA. This can be one of the main reasons why people with MSA are so susceptible to getting urinary tract infections (UTI's).
About 1/3 of people with MSA die while still misdiagnosed. Only 25% of patients with MSA are correctly diagnosed at their first neurological visit. The correct diagnosis is usually established on an average of 4 to 5 years after the disease onset.
MSA causes parts of the brain to shrink. This is known as atrophy. The areas of the brain that shrink due to MSA include the cerebellum, basal ganglia and brainstem. The atrophy of these parts of the brain affect internal body functions and movement.
Offer to do the shopping. Help with everyday tasks round the house such as hanging the washing out, doing the hoovering etc. Share your computer and technology skills with them, these can be a lifeline for people with MSA but they may need help learning to use them.
The approximate rate of effectiveness of levodopa in multiple system atrophy (MSA) has been reported as 30-65% in both clinical and pathological cases (1-3). The pathological background in which levodopa is effective has mainly been studied with a focus on putaminal lesions (4,5).
Indeed, a patient with MSA may present with vocal fold paralysis, and respiratory distress may be the initial symptom. Vocal fold paralysis may go unrecognized, as it presents insidiously and patients may develop some tolerance during its initial progression.
Currently, there are no treatments to stop or slow the progression of MSA, and there is no cure. However, there are treatments to help people cope with the symptoms.
MSA affects people in different ways, depending on which muscles are affected. Some of the most common symptoms include: bladder problems, such as needing to pee more often or being unable to pee. feeling dizzy and faint when standing up.
Two crucial symptoms you should never ignore are sudden, severe headaches (like "the worst headache of your life") and sudden weakness, numbness, or slurred speech on one side of the body, as these can signal a stroke or brain issue, requiring immediate medical help. Other critical signs include chest pain, shortness of breath, unexplained weight loss, and persistent confusion or changes in bowel habits, all pointing to potentially serious underlying conditions.
One significant red flag is the presence of persistent back pain that worsens at night and hinders sleep. If the pain becomes progressively worse or is accompanied by other symptoms such as numbness, tingling, or weakness in the legs, it may indicate nerve compression or spinal cord involvement.
Examples of such symptoms include: